Jab1-BMP signaling interaction in chondrocyte differentiation
Jab1-BMP 信号在软骨细胞分化中的相互作用
基本信息
- 批准号:9273260
- 负责人:
- 金额:$ 34.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAcuteAddressAdverse effectsAffectApoptosisAttenuatedBMP2 geneBMP7 geneBone Morphogenetic ProteinsBone RegenerationCOPS5 geneCartilageCell Cycle ProgressionCell Differentiation processChIP-seqChondrocytesClinicalDefectDegenerative DisorderDegenerative polyarthritisDevelopmentDevelopmental ProcessDiagnosisDoseDwarfismEmbryoEmbryonic DevelopmentEnsureExhibitsFamilyFeedbackFractureGap JunctionsGene ExpressionGene Expression ProfileGene Expression ProfilingGeneticGenetic TranscriptionGoalsGrowthHealth systemHistologicHumanHypertrophyImplantIn SituInflammatoryJoint repairLeadMalignant NeoplasmsMediatingMediationModelingMolecularMolecular ProfilingMusMusculoskeletalMutationNatural regenerationNeonatalOsteogenesisPainPatientsPhosphorylationPhysiologicalPlayPreventionProteinsPublishingResearchRoleSignal PathwaySignaling ProteinSkeletal DevelopmentSpinal FusionTestingTransactivationTraumaTreatment EfficacyWorkbasebone healingcartilage repairchondrodysplasiacofactorcostdosageexperimental studygain of functiongenetic manipulationimprovedin vivoinhibitor/antagonistlong boneloss of functionmutantmutant mouse modelnovelnovel therapeuticsosteogenicoverexpressionparathyroid hormone-related proteinpublic health relevancerecombinase-mediated cassette exchangerepairedresponseskeletalskeletal disorderskeletal dysplasiaskeletogenesisspatiotemporaltherapeutic targettranscription factortranscriptome sequencingwhole genome
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to understand the interaction of Jab1 and BMP signaling during chondrocyte differentiation. BMP signaling is important for all aspects of cartilage and bone formation, bone healings, and joint and cartilage repair. BMP2- and BMP7-containing osteogenic implants have been used for bone regeneration in over one million patients worldwide in the treatment of long-bone nonunion and acute fracture and in spinal fusion. However, the clinical use of BMPs requires super-physiological doses, resulting in high cost and potential inflammatory side effects. Thus, improving BMP treatment efficacy is critical to ease physical pain and financial burdens on patients, their families, and or health system. Furthermore, mutations in BMP signaling components lead to severe human skeletal developmental defects. We have recently identified transcriptional cofactor Jab1 as a novel inhibitor of BMP signaling downstream effector Smad1/5. Jab1 plays essential roles during various developmental processes by modulating other transcription factors' function. Jab1 is broadly expressed during embryogenesis, including in the chondrocytes. However, the role of Jab1 in cartilage formation remains mostly unknown. In our preliminary study, the loss of Jab1 specifically in chondrocytes using the loxP/Cre system led to neonatal lethal chondrodysplasia in mice, demonstrating that Jab1 is essential for proper cartilage formation in vivo. Furthermore, gene expression profiling and ex vivo culture experiments with Jab1 deficient primary chondrocytes revealed increased expression of Smad1/5 and its downstream targets Ihh and Col10a1. Thus, we hypothesize that Jab1 regulates chondrocyte differentiation by directly repressing Smad1/5-mediated BMP signaling. In this study, we propose three specific aims to test this hypothesis. Aim 1 is to use complementary cellular and molecular approaches to delineate the underlying mechanism of Jab1-BMP signaling interaction in chondrocyte differentiation. Aim 2 is to determine the effect of the genetic manipulation of Jab1 expression (both gain- and loss-of-function), specifically in chondrocytes in an inducible manner, on BMP-mediated embryonic cartilage formation using histological and in situ analysis. Aim 3 is to use RNA-seq and ChIP-seq to investigate the direct Jab1 downstream targets in chondrocytes. Overall, this study will further our understanding of the essential role of Jab1 in BMP-mediated skeletal development and generate novel mutant mouse models for skeletal dysplasia research. Ultimately, new therapies based on controlling the Jab1-mediated inhibition of BMP signaling will open a new era in treating acute fracture, osteoarthritis, and the skeletal disorders associated with dys-regulated BMP signaling.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guang Zhou其他文献
Guang Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guang Zhou', 18)}}的其他基金
The Role of JAB1 in osteosarcoma pathogenesis
JAB1在骨肉瘤发病机制中的作用
- 批准号:
8637020 - 财政年份:2013
- 资助金额:
$ 34.87万 - 项目类别:
The Role of JAB1 in osteosarcoma pathogenesis
JAB1在骨肉瘤发病机制中的作用
- 批准号:
8492286 - 财政年份:2013
- 资助金额:
$ 34.87万 - 项目类别:
Regulation of Craniofacial Skeletal Development by Jab1
Jab1 对颅面骨骼发育的调节
- 批准号:
7797581 - 财政年份:2009
- 资助金额:
$ 34.87万 - 项目类别:
Regulation of Craniofacial Skeletal Development by Jab1
Jab1 对颅面骨骼发育的调节
- 批准号:
7932574 - 财政年份:2009
- 资助金额:
$ 34.87万 - 项目类别:
Regulation of Craniofacial Skeletal Development by Jab1
Jab1 对颅面骨骼发育的调节
- 批准号:
7660695 - 财政年份:2009
- 资助金额:
$ 34.87万 - 项目类别:
Genetic Interaction Between SOX9 and RUNX2/CBFA1
SOX9 和 RUNX2/CBFA1 之间的遗传相互作用
- 批准号:
6603404 - 财政年份:2003
- 资助金额:
$ 34.87万 - 项目类别:
Genetic Interaction Between SOX9 and RUNX2/CBFA1
SOX9 和 RUNX2/CBFA1 之间的遗传相互作用
- 批准号:
7120408 - 财政年份:2003
- 资助金额:
$ 34.87万 - 项目类别:
Genetic Interaction Between SOX9 and RUNX2/CBFA1during chondrogenesis
软骨形成过程中 SOX9 和 RUNX2/CBFA1 之间的遗传相互作用
- 批准号:
7332258 - 财政年份:2003
- 资助金额:
$ 34.87万 - 项目类别:
Genetic Interaction Between SOX9 and RUNX2/CBFA1during chondrogenesis
软骨形成过程中 SOX9 和 RUNX2/CBFA1 之间的遗传相互作用
- 批准号:
7119034 - 财政年份:2003
- 资助金额:
$ 34.87万 - 项目类别:
Genetic Interaction Between SOX9 and RUNX2/CBFA1
SOX9 和 RUNX2/CBFA1 之间的遗传相互作用
- 批准号:
6897593 - 财政年份:2003
- 资助金额:
$ 34.87万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 34.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Operating Grants